4.
Alieva A.V., Ismailov S.I., Raximova G.N., Epidemiology of diabetes mellitus and
prediabetes in Uzbekistan: screening results. J.Teor. and Klin.Med.-2017.- №2. - S. 58-61.
5.
Barnard K, Peveler RC, Holt RIG (2013) Antidepressant medication as a risk factor for type
2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 36:3337–45.
doi: 10.2337/dc13-0560
6.
Pyykkönen A-J, Räikkönen K, Tuomi T, et al (2012) Association between depressive
symptoms and metabolic syndrome is not explained by antidepressant medication: results
from the PPP-Botnia Study. Ann Med 44:279–88. doi: 10.3109/07853890.2010.543921
7.
Wells G, Shea B, O’Connell D, Peterson J (2012) The Newcastle-Ottawa Scale (NOS) for
assessing the quality if nonrandomized studies in meta-analysis. Ottawa Heal. Res. Insititute
Website
Do'stlaringiz bilan baham: |